Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Glucagon like peptide-1 (GLP-1) agonists Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global Glucagon like peptide-1 (GLP-1) agonists market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Glucagon like peptide-1 (GLP-1) agonists market competition by top manufacturers/players, with Glucagon like peptide-1 (GLP-1) agonists sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists for each application, including
Hospital
Pharmacy
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global Glucagon like peptide-1 (GLP-1) agonists Sales Market Report 2017
1 Glucagon like peptide-1 (GLP-1) agonists Market Overview
1.1 Product Overview and Scope of Glucagon like peptide-1 (GLP-1) agonists
1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists by Product Category
1.2.1 Global Glucagon like peptide-1 (GLP-1) agonists Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Glucagon like peptide-1 (GLP-1) agonists Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Exenatied
1.2.4 Liraglutide
1.2.5 Lixisenatide
1.2.6 Albiglutide
1.2.7 Dulaglutide
1.3 Global Glucagon like peptide-1 (GLP-1) agonists Market by Application/End Users
1.3.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Glucagon like peptide-1 (GLP-1) agonists Market by Region
1.4.1 Global Glucagon like peptide-1 (GLP-1) agonists Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Glucagon like peptide-1 (GLP-1) agonists Status and Prospect (2012-2022)
1.4.3 China Glucagon like peptide-1 (GLP-1) agonists Status and Prospect (2012-2022)
1.4.4 Europe Glucagon like peptide-1 (GLP-1) agonists Status and Prospect (2012-2022)
1.4.5 Japan Glucagon like peptide-1 (GLP-1) agonists Status and Prospect (2012-2022)
1.4.6 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Status and Prospect (2012-2022)
1.4.7 India Glucagon like peptide-1 (GLP-1) agonists Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Glucagon like peptide-1 (GLP-1) agonists (2012-2022)
1.5.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2012-2022)
1.5.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2012-2022)

2 Global Glucagon like peptide-1 (GLP-1) agonists Competition by Players/Suppliers, Type and Application
2.1 Global Glucagon like peptide-1 (GLP-1) agonists Market Competition by Players/Suppliers
2.1.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Glucagon like peptide-1 (GLP-1) agonists (Volume and Value) by Type
2.2.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type (2012-2017)
2.2.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Type (2012-2017)
2.3 Global Glucagon like peptide-1 (GLP-1) agonists (Volume and Value) by Region
2.3.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Region (2012-2017)
2.3.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Region (2012-2017)
2.4 Global Glucagon like peptide-1 (GLP-1) agonists (Volume) by Application

3 United States Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
3.1 United States Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2012-2017)
3.1.1 United States Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2012-2017)
3.1.2 United States Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2012-2017)
3.1.3 United States Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2012-2017)
3.2 United States Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Players
3.3 United States Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
3.4 United States Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

4 China Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
4.1 China Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2012-2017)
4.1.1 China Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2012-2017)
4.1.2 China Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2012-2017)
4.1.3 China Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2012-2017)
4.2 China Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Players
4.3 China Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
4.4 China Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

5 Europe Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
5.1 Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2012-2017)
5.1.1 Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2012-2017)
5.1.2 Europe Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2012-2017)
5.1.3 Europe Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2012-2017)
5.2 Europe Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Players
5.3 Europe Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
5.4 Europe Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

6 Japan Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
6.1 Japan Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2012-2017)
6.1.1 Japan Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2012-2017)
6.1.2 Japan Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2012-2017)
6.1.3 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2012-2017)
6.2 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Players
6.3 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
6.4 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

7 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
7.1 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2012-2017)
7.1.1 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2012-2017)
7.2 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Players
7.3 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
7.4 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

8 India Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
8.1 India Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2012-2017)
8.1.1 India Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2012-2017)
8.1.2 India Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2012-2017)
8.1.3 India Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2012-2017)
8.2 India Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Players
8.3 India Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
8.4 India Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

9 Global Glucagon like peptide-1 (GLP-1) agonists Players/Suppliers Profiles and Sales Data
9.1 Novo Nordisk
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 AstraZeneca
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Eli Lily
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Eli Lily Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GSK
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 GSK Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Sanofi
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Sanofi Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Bristol-Myers Squibb
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Amylin
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Amylin Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
...

10 Glucagon like peptide-1 (GLP-1) agonists Maufacturing Cost Analysis
10.1 Glucagon like peptide-1 (GLP-1) agonists Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists
10.3 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Glucagon like peptide-1 (GLP-1) agonists Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Glucagon like peptide-1 (GLP-1) agonists Market Forecast (2017-2022)
14.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Glucagon like peptide-1 (GLP-1) agonists Price and Trend Forecast (2017-2022)
14.2 Global Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Type (2017-2022)
14.3.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue Forecast by Type (2017-2022)
14.3.3 Global Glucagon like peptide-1 (GLP-1) agonists Price Forecast by Type (2017-2022)
14.4 Global Glucagon like peptide-1 (GLP-1) agonists Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 24 hours.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37963

Category: 16

Published date: 2017-12-03 20:12:16

Number of Pages: 104

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)